Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Nasopharyngeal Carcinoma

Clinical trial condition

Recurrent Nasopharyngeal Carcinoma

Explore clinical trials studying Recurrent Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

13 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Nasopharyngeal Carcinoma trial results

Completed

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

NCT01392235

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +13 more
Locations: Department of Medical Oncology, Cancer Center, Sun Yet-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

MK-2206 in Recurrent Nasopharyngeal Carcinoma

NCT01370070

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Active, Not Recruiting

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

NCT03930498

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details